Track market-moving stories before they get noisy

The People's Bank of China (PBOC) sets the USD/CNY central rate for the trading session ahead on Tuesday at 6.7150 compared to the previous day's fix of 6.7146 and 6.6489 Reuters estimate.

Wix.com (WIX - Free Report) closed at $74.95 in the latest trading session, marking a -2.75% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 0.51%. Elsewhere, the Dow saw an upswing of 0.41%, while the tech-heavy Nasdaq depreciated by 1.07%.

Coming into today, shares of the cloud-based web development company had gained 6.13% in the past month. In that same time, the Computer and Technology sector lost 9.88%, while the S&P 500 lost 0.87%.

The investment community will be paying close attention to the earnings performance of Wix.com in its upcoming release. The company is slated to reveal its earnings on November 10, 2026. The company's earnings per share (EPS) are projected to be $1.3, reflecting a 22.62% decrease from the same quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $566.8 million, reflecting a 12.2% rise from the equivalent quarter last year.

In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $4.28 per share and a revenue of $2.26 billion, indicating changes of -41.53% and +13.29%, respectively, from the former year.

Any recent changes to analyst estimates for Wix.com should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. As of now, Wix.com holds a Zacks Rank of #3 (Hold).

In terms of valuation, Wix.com is presently being traded at a Forward P/E ratio of 18.02. For comparison, its industry has an average Forward P/E of 15.29, which means Wix.com is trading at a premium to the group.

Also, we should mention that WIX has a PEG ratio of 2.04. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. WIX's industry had an average PEG ratio of 1.21 as of yesterday's close.

The Computers - IT Services industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 103, which puts it in the top 42% of all 250+ industries.

The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Ross Stores (ROST - Free Report) closed at $230.59 in the latest trading session, marking a +1.01% move from the prior day. This change outpaced the S&P 500's 0.51% loss on the day. Elsewhere, the Dow gained 0.41%, while the tech-heavy Nasdaq lost 1.07%.

Prior to today's trading, shares of the discount retailer had lost 0.11% lagged the Retail-Wholesale sector's gain of 3.73% and was narrower than the S&P 500's loss of 0.87%.

Market participants will be closely following the financial results of Ross Stores in its upcoming release. On that day, Ross Stores is projected to report earnings of $1.82 per share, which would represent year-over-year growth of 15.19%. Meanwhile, our latest consensus estimate is calling for revenue of $6.2 billion, up 10.68% from the prior-year quarter.

Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $8.77 per share and revenue of $25.65 billion. These totals would mark changes of +32.68% and +12.76%, respectively, from last year.

Investors should also take note of any recent adjustments to analyst estimates for Ross Stores. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.

Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Right now, Ross Stores possesses a Zacks Rank of #3 (Hold).

Looking at its valuation, Ross Stores is holding a Forward P/E ratio of 26.02. This valuation marks a premium compared to its industry average Forward P/E of 19.9.

It's also important to note that ROST currently trades at a PEG ratio of 1.89. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. By the end of yesterday's trading, the Retail - Discount Stores industry had an average PEG ratio of 1.89.

The Retail - Discount Stores industry is part of the Retail-Wholesale sector. At present, this industry carries a Zacks Industry Rank of 57, placing it within the top 24% of over 250 industries.

The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.

Image: Bigstock

Read MoreHide Full Article

For the quarter ended September 2026, Camping World (CWH - Free Report) reported revenue of $1.58 billion, down 12.4% over the same period last year. EPS came in at -$0.19, compared to $0.43 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.68 billion, representing a surprise of -6.02%. The company delivered an EPS surprise of -218.75%, with the consensus EPS estimate being $0.16.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Camping World performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Unit sales - New vehicle: 15,126 versus the two-analyst average estimate of 16,466.Average selling price - Used vehicles: $30,187.00 versus $31,321.12 estimated by two analysts on average.Average selling price - New vehicles: $42,239.00 versus the two-analyst average estimate of $38,015.06.Unit sales - Used vehicle: 17,176 versus the two-analyst average estimate of 18,940.Revenue- RV and Outdoor Retail- New vehicles: $638.9 million compared to the $656.87 million average estimate based on three analysts. The reported number represents a change of -16.7% year over year.Revenue- RV and Outdoor Retail- Used vehicles: $518.49 million versus $585.19 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -12% change.Revenue- RV and Outdoor Retail- Products, service and other: $208.99 million versus $208.64 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +0.2% change.Revenue- RV and Outdoor Retail- Good Sam Club: $18.98 million versus $12.13 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +75.6% change.Revenue- Good Sam Services and Plans: $50.07 million versus $52.31 million estimated by three analysts on average.Revenue- RV and Outdoor Retail: $1.53 billion versus $1.63 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -12.6% change.Revenue- RV and Outdoor Retail- Finance and insurance, net: $147.48 million versus the three-analyst average estimate of $169.11 million. The reported number represents a year-over-year change of -17.3%.Gross Profit- RV and Outdoor Retail- Products, Service and Other: $79.95 million compared to the $95.28 million average estimate based on three analysts.View all Key Company Metrics for Camping World here>>>

Shares of Camping World have returned -0.6% over the past month versus the Zacks S&P 500 composite's -0.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Published in earnings earnings-estimates-revisions earnings-surprise

Celanese (CE - Free Report) came out with quarterly earnings of $1.65 per share, beating the Zacks Consensus Estimate of $1.52 per share. This compares to earnings of $1.34 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +8.55%. A quarter ago, it was expected that this chemical company would post earnings of $2.21 per share when it actually produced earnings of $2.45, delivering a surprise of +10.86%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

Celanese, which belongs to the Zacks Chemical - Specialty industry, posted revenues of $2.56 billion for the quarter ended September 2026, missing the Zacks Consensus Estimate by 0.78%. This compares to year-ago revenues of $2.42 billion. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Celanese shares have added about 16.6% since the beginning of the year versus the S&P 500's gain of 10.7%.

What's Next for Celanese?While Celanese has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Celanese was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.11 on $2.33 billion in revenues for the coming quarter and $6.00 on $9.95 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Specialty is currently in the top 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Neo Performance Materials Inc. (NOPMF - Free Report) , has yet to report results for the quarter ended September 2026. The results are expected to be released on November 10.

This company is expected to post quarterly earnings of $0.42 per share in its upcoming report, which represents a year-over-year change of +121.1%. The consensus EPS estimate for the quarter has been revised 9.1% lower over the last 30 days to the current level.

Neo Performance Materials Inc.'s revenues are expected to be $186.98 million, up 53% from the year-ago quarter.

NetApp (NTAP - Free Report) ended the recent trading session at $185.26, demonstrating a -6.99% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily loss of 0.51%. On the other hand, the Dow registered a gain of 0.41%, and the technology-centric Nasdaq decreased by 1.07%.

Shares of the data storage company witnessed a loss of 11.97% over the previous month, trailing the performance of the Computer and Technology sector with its loss of 9.88%, and the S&P 500's loss of 0.87%.

The investment community will be paying close attention to the earnings performance of NetApp in its upcoming release. The company is slated to reveal its earnings on December 1, 2026. The company's earnings per share (EPS) are projected to be $2.6, reflecting a 26.83% increase from the same quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.11 billion, up 23.83% from the year-ago period.

For the full year, the Zacks Consensus Estimates are projecting earnings of $10.05 per share and revenue of $8.23 billion, which would represent changes of +23.62% and +18.91%, respectively, from the prior year.

Any recent changes to analyst estimates for NetApp should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. NetApp presently features a Zacks Rank of #1 (Strong Buy).

In terms of valuation, NetApp is presently being traded at a Forward P/E ratio of 19.82. This expresses a premium compared to the average Forward P/E of 12.65 of its industry.

We can additionally observe that NTAP currently boasts a PEG ratio of 1.77. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. NTAP's industry had an average PEG ratio of 1.25 as of yesterday's close.

The Computer- Storage Devices industry is part of the Computer and Technology sector. At present, this industry carries a Zacks Industry Rank of 23, placing it within the top 10% of over 250 industries.

The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.

Check Point Software Technologies Ltd. (CHKP) Q3 2026 Earnings Call November 2, 2026 8:30 AM EST

Company Participants

Kip Meintzer - Head of Global Investor Relations
Nadav Zafrir - CEO & Director
Roei Golan - Chief Financial Officer

Conference Call Participants

John DiFucci - Guggenheim Securities, LLC, Research Division
Joseph Gallo - Jefferies LLC, Research Division
Patrick Edwin Colville - Scotiabank Global Banking and Markets, Research Division
Todd Weller - Stephens Inc., Research Division
Adam Tindle - Raymond James & Associates, Inc., Research Division
Shrenik Kothari - Robert W. Baird & Co. Incorporated, Research Division
Joshua Tilton - Wolfe Research, LLC
Junaid Siddiqui - Truist Securities, Inc., Research Division
Saket Kalia - Barclays Bank PLC, Research Division
Brad Zelnick - Deutsche Bank AG, Research Division
Richard Poland - Wells Fargo Securities, LLC, Research Division

Presentation

Kip Meintzer
Head of Global Investor Relations

Greetings, and welcome to Check Point Software's 2026 Third Quarter Financial Results Video Conference. I'm Kip E. Meintzer, Global Head of Investor Relations.

Joining me today are Chief Executive Officer, Nadav Zafrir; and our Chief Financial Officer, Roei Golan. Before we begin, I'd like to remind everyone that this conference is being recorded and will be available for replay on our website at checkpoint.com.

[Operator Instructions]

During the presentation, Check Point's representatives may make forward-looking statements. Forward-looking statements generally relate to future events or our future financial or operating performance. These statements involve risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements.

Any forward-looking statements made speak only as of the date hereof, and Check Point Software undertakes no obligation to update publicly any forward-looking statements. In our press release, which has been posted on our website, we present GAAP and non-GAAP results, along with a reconciliation of such results as well as the reasons for our presentation of non-GAAP information. If you have any questions

US Stock Market Fails To Recover as $700 Billion Comeback Collapses

In the latest close session, Rocket Lab Corporation (RKLB - Free Report) was down 4.86% at $52.07. This move lagged the S&P 500's daily loss of 0.51%. On the other hand, the Dow registered a gain of 0.41%, and the technology-centric Nasdaq decreased by 1.07%.

Prior to today's trading, shares of the company had lost 25.96% lagged the Aerospace sector's gain of 2.1% and the S&P 500's loss of 0.87%.

Analysts and investors alike will be keeping a close eye on the performance of Rocket Lab Corporation in its upcoming earnings disclosure. The company's earnings report is set to go public on November 9, 2026. The company's upcoming EPS is projected at -$0.02, signifying a 300.00% drop compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $256.51 million, reflecting a 65.4% rise from the equivalent quarter last year.

Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$0.05 per share and revenue of $952.35 million, indicating changes of +81.48% and +58.25%, respectively, compared to the previous year.

Investors should also note any recent changes to analyst estimates for Rocket Lab Corporation. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.

Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. At present, Rocket Lab Corporation boasts a Zacks Rank of #3 (Hold).

The Aerospace - Defense Equipment industry is part of the Aerospace sector. This industry, currently bearing a Zacks Industry Rank of 79, finds itself in the top 33% echelons of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.

Neurocrine Biosciences (NBIX - Free Report) reported $1.12 billion in revenue for the quarter ended September 2026, representing a year-over-year increase of 41.2%. EPS of $3.29 for the same period compares to $2.04 a year ago.

The reported revenue represents a surprise of +8.12% over the Zacks Consensus Estimate of $1.04 billion. With the consensus EPS estimate being $2.54, the EPS surprise was +29.53%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Neurocrine performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Revenues- Product sales, net: $1.12 billion versus $1.04 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +41.7% change.Revenues- Product sales, net- CRENESSITY: $211 million versus $200.42 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +115.1% change.Revenues- Collaboration revenue: $3.7 million compared to the $6.68 million average estimate based on seven analysts. The reported number represents a change of -26% year over year.Revenues- Product sales, net- INGREZZA: $801 million versus the seven-analyst average estimate of $736.52 million. The reported number represents a year-over-year change of +16.7%.View all Key Company Metrics for Neurocrine here>>>

Shares of Neurocrine have returned +2% over the past month versus the Zacks S&P 500 composite's -0.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Williams Companies, Inc. (The) (WMB - Free Report) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.49 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -1.82%. A quarter ago, it was expected that this pipeline operator would post earnings of $0.52 per share when it actually produced earnings of $0.5, delivering a surprise of -3.85%.

Over the last four quarters, the company has surpassed consensus EPS estimates just once.

The Williams Companies, which belongs to the Zacks Oil and Gas - Production and Pipelines industry, posted revenues of $3.22 billion for the quarter ended September 2026, surpassing the Zacks Consensus Estimate by 1.19%. This compares to year-ago revenues of $2.92 billion. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

The Williams Companies shares have added about 23.7% since the beginning of the year versus the S&P 500's gain of 10.7%.

What's Next for The Williams Companies?While The Williams Companies has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for The Williams Companies was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.63 on $3.58 billion in revenues for the coming quarter and $2.56 on $12.99 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Oil and Gas - Production and Pipelines is currently in the bottom 19% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Enbridge (ENB - Free Report) , has yet to report results for the quarter ended September 2026. The results are expected to be released on November 6.

This oil and natural gas transportation and power transmission company is expected to post quarterly earnings of $0.36 per share in its upcoming report, which represents a year-over-year change of +9.1%. The consensus EPS estimate for the quarter has been revised 0.3% higher over the last 30 days to the current level.

Enbridge's revenues are expected to be $10.32 billion, down 2.9% from the year-ago quarter.

Aehr Test Systems Soars Again on Latest Orders, Jefferies Eyes Big-Time Upside AheadAehr Test Systems NASDAQ: AEHR reported record revenue and sharply higher bookings for its fiscal 2027 first quarter, citing expanding demand for wafer-level and package-level burn-in systems used in artificial intelligence, data center and power-semiconductor applications.

Revenue for the quarter reached $33.0 million, up 200% from $11.0 million in the prior-year period and 75% sequentially. Non-GAAP net income was $9.4 million, or $0.28 per diluted share, compared with $0.2 million, or $0.01 per diluted share, a year earlier. The company said its results reflected increased production demand for AI semiconductor testing and reliability screening.

Get Aehr Test Systems alerts:

Flash in the Pan or Sustained Rally Contender? 3 Momentum Stocks to Watch“We delivered an outstanding start to fiscal 2027 with record quarterly revenue, strong bookings, and significant progress across several major AI semiconductor customer programs,” President and Chief Executive Officer Gayn Erickson said on the company’s earnings call.

Bookings, Backlog and Raised Outlook First-quarter bookings totaled $46.7 million, more than four times the $11.4 million reported in the prior-year quarter. The company recorded a book-to-bill ratio of 1.4. Quarter-end backlog was $100.9 million, rising from $80.6 million at the end of fiscal 2026, while effective backlog, including $8.4 million of orders received after quarter-end, reached $109.3 million as of Nov. 1.

Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue GrowthBased on first-quarter performance, backlog and production visibility, Aehr raised its fiscal 2027 revenue outlook to $150 million from a previous range of $130 million to $150 million. The company said the outlook would represent 200% annual revenue growth, or triple fiscal 2026 revenue. It continues to expect non-GAAP net income of at least 20% of revenue for the full year.

Chief Financial Officer Chris Siu said the company expects another strong second quarter, supported by systems scheduled for shipment to its lead hyperscale customer. Erickson said revenue is expected to increase through the remaining quarters of the fiscal year, though customer order timing and shipment schedules can vary.

AI Programs Drive Wafer-Level and Package-Level Demand Aehr said its lead AI processor production customer is continuing to add wafer-level burn-in capacity. In August, the company announced a $22 million follow-on order for fully automated FOX-XP systems, WaferPak auto aligners and proprietary WaferPak full-wafer contactors.

The company also said a major supplier of AI accelerators, CPUs and network processors has elected to purchase a fully configured FOX-XP wafer-level burn-in test cell following a successful benchmark evaluation. The system is expected to be installed at an outsourced semiconductor assembly and test partner in Taiwan in early calendar 2027. Aehr said the customer plans to evaluate the system in a high-volume environment, with a decision on broader production deployment expected several months after installation and validation.

Erickson characterized the engagement as among the company’s largest potential opportunities, pointing to rising chip complexity and the need to detect early-life failures before processors are integrated into costly multi-die packages containing memory and input/output components.

On the package-level side, Aehr said it is shipping and installing more than a dozen Sonoma high-power burn-in systems per month for its lead hyperscale customer’s first AI processor. The customer’s second AI processor has completed qualification on Sonoma, and Aehr has received follow-on orders for systems, burn-in modules and software enhancements supporting initial production sampling and an anticipated calendar 2027 ramp.

The second processor requires higher power and more complex thermal management, including multiple independently controlled thermal zones within a package, according to the company. Aehr said the customer expects the second processor eventually to reach higher volumes than the first processor currently in production on Sonoma.

Consumables, Manufacturing Capacity and Margins Revenue from contactors and related products—including WaferPaks, burn-in modules and burn-in boards—totaled $13.5 million, or 41% of first-quarter revenue, compared with $2.6 million, or 24% of revenue, a year earlier. Aehr expects consumables to represent about 35% of fiscal 2027 revenue, compared with 29% in fiscal 2026.

The company said consumable demand is tied to its growing installed base as customers expand production volumes and introduce new devices. It also cited additional production orders for silicon photonics applications, improving silicon carbide demand, and two additional gallium nitride production customers added during the past six months.

To support production ramps, Aehr has expanded manufacturing and support operations in Southeast Asia and Taiwan. The company began shipping Sonoma systems from an existing Southeast Asian contract manufacturing site during the quarter, adding capacity for more than 20 additional Sonoma systems per month. It also signed a lease in Hsinchu, Taiwan, and is adding customer-service resources there.

Non-GAAP gross margin rose to 48.5% from 37.5% a year earlier, driven by higher sales volumes and a more favorable product mix. Siu said the company expects full-year fiscal 2027 gross margin to remain near the first-quarter range, although quarterly results may vary and the second quarter could be lower because of the expected Sonoma shipment mix.

Cash Position and Investment Priorities Non-GAAP operating expenses increased to $7.8 million from $5.7 million in the prior-year period, primarily due to research and development spending on AI-related programs, next-generation package-level burn-in and memory initiatives. Despite the higher spending, revenue growth outpaced expense growth, the company said.

Aehr used $3.1 million in operating cash flow during the quarter, largely reflecting working-capital investments and purchases of long-lead-time components intended to support anticipated AI-related demand. The company ended the quarter with $105.1 million in cash, cash equivalents and restricted cash, down from $116.5 million at the end of fiscal 2026, and said it remained debt-free.

The company also appointed Vijay Rao to its board of directors. Aehr said Rao brings 30 years of technology-industry experience, including expertise in hyperscale data center infrastructure, AI accelerators, high-performance memory and optical networking.

About Aehr Test Systems (NASDAQ:AEHR)Aehr Test Systems NASDAQ: AEHR develops and manufactures test and burn-in equipment used to qualify and screen semiconductor devices. Its systems are designed to identify manufacturing defects and reliability issues before chips are shipped to customers, helping semiconductor manufacturers improve production yields and product quality.

The company's product portfolio includes the FOX family of semiconductor test systems, including the FOX-XP, FOX-NP and FOX-1P platforms. Aehr also provides wafer contactors, DiePak carriers and related test fixtures and software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Aehr Test Systems Right Now?Before you consider Aehr Test Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aehr Test Systems wasn't on the list.

While Aehr Test Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

NRG Energy (NRG - Free Report) closed at $94.62 in the latest trading session, marking a -1.5% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.51% for the day. Elsewhere, the Dow saw an upswing of 0.41%, while the tech-heavy Nasdaq depreciated by 1.07%.

The power company's stock has climbed by 0.87% in the past month, falling short of the Utilities sector's gain of 8.2% and outpacing the S&P 500's loss of 0.87%.

Market participants will be closely following the financial results of NRG Energy in its upcoming release. The company plans to announce its earnings on November 9, 2026. In that report, analysts expect NRG Energy to post earnings of $3.33 per share. This would mark year-over-year growth of 21.09%. Meanwhile, the latest consensus estimate predicts the revenue to be $6.72 billion, indicating a 11.92% decrease compared to the same quarter of the previous year.

For the annual period, the Zacks Consensus Estimates anticipate earnings of $8.62 per share and a revenue of $33.34 billion, signifying shifts of +6.82% and +8.54%, respectively, from the last year.

Investors should also take note of any recent adjustments to analyst estimates for NRG Energy. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.

Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.

The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.08% higher within the past month. NRG Energy is currently a Zacks Rank #3 (Hold).

Investors should also note NRG Energy's current valuation metrics, including its Forward P/E ratio of 11.15. This denotes a discount relative to the industry average Forward P/E of 17.33.

The Utility - Electric Power industry is part of the Utilities sector. Currently, this industry holds a Zacks Industry Rank of 98, positioning it in the top 40% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.

The AI trade has seen volatility recently, with many of the market's biggest winners coming under pressure as investors increasingly question the massive spending surrounding the technology.

Concerns surrounding stretched valuations and the overall return on AI investments have been major contributors to the weakness, with investors seemingly becoming more selective despite the continued growth story.

Given the recent volatility, this week's earnings releases from Super Micro Computer (SMCI - Free Report) , Advanced Micro Devices (AMD - Free Report) , and Arm Holdings (ARM - Free Report) will undoubtedly be closely watched, particularly concerning the overall AI demand picture.

Let's take a closer look at a few key metrics to watch in each release.

Super Micro Computer

Super Micro Computer, a provider of AI-optimized servers and infrastructure solutions, reports Tuesday, November 3rd. Growth expectations remain sizable, with the Zacks Consensus Estimate calling for $15.7 billion in sales and earnings of $1.24 per share, reflecting 214% and 254% YoY growth, respectively.

AI server demand will be the primary focus, particularly concerning its liquid-cooling solutions and rack-scale systems. The company's ability to convert robust demand into profitable growth will also be critical, making gross margins a key metric to watch.

Importantly, management's sales outlook for the coming quarters should provide further visibility into the AI infrastructure spending picture.

Advanced Micro Devices

Advanced Micro Devices also reports Tuesday, with investors undoubtedly focused on its Data Center results, which have been a major growth driver thanks to demand for its EPYC processors and Instinct AI accelerators.

Our latest Zacks Consensus estimates call for $13.1 billion in sales and earnings of $1.94 per share, reflecting 42% revenue growth on 62% higher earnings. Beyond Data Center sales, investors should watch commentary on its next-generation AI accelerators, customer adoption, and the overall GPU demand pipeline.

Arm Holdings

Arm Holdings rounds out the trio, reporting Wednesday, November 4th. The company licenses semiconductor intellectual property, with its energy-efficient CPU designs becoming increasingly important across data centers and AI-related applications.

Current analyst consensus estimates call for roughly $1.4 billion in sales and earnings of $0.48 per share, suggesting 21% revenue growth on 23% higher earnings. Royalty revenue will be a major focus, particularly concerning the growing adoption of Arm-based processors in cloud infrastructure. Licensing results and continued adoption of its newer architectures will also provide insights into the longer-term growth picture.

Bottom Line

AI-related earnings remain a major theme throughout the current reporting cycle, with Super Micro Computer (SMCI - Free Report) , Advanced Micro Devices (AMD - Free Report) , and Arm Holdings (ARM - Free Report) all gearing up for releases this week.

Beyond the headline results, commentary surrounding AI demand, customer adoption, and forward guidance will be critical in determining whether their impressive growth trajectories can continue.

For the quarter ended September 2026, Vertex Pharmaceuticals (VRTX - Free Report) reported revenue of $3.44 billion, up 11.9% over the same period last year. EPS came in at $4.76, compared to $4.80 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $3.4 billion, representing a surprise of +1.11%. The company delivered an EPS surprise of -3.25%, with the consensus EPS estimate being $4.92.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Vertex performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Revenues by Product- Trikafta/Kaftrio: $2.44 billion versus $2.49 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -8.2% change.Revenues by Product- Other CF product revenues: $130.5 million versus the four-analyst average estimate of $125.43 million. The reported number represents a year-over-year change of -25.8%.Revenues by Product- ALYFTREK: $705.8 million compared to the $631 million average estimate based on four analysts. The reported number represents a change of +185.8% year over year.Revenues- Product revenues, net: $3.44 billion versus the two-analyst average estimate of $3.39 billion. The reported number represents a year-over-year change of +11.9%.View all Key Company Metrics for Vertex here>>>

Shares of Vertex have returned +10.7% over the past month versus the Zacks S&P 500 composite's -0.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

10.15K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

This article is intended to provide informational content and should not be viewed as an exhaustive analysis of the featured company. It should not be interpreted as personalized investment advice with regard to 'Buy/Sell/Hold/Short/Long' recommendations. Financial models presented here, including DCF, rNPV, and scenario analyses, are illustrative tools based on the author's assumptions and are highly sensitive to inputs; small changes can materially alter outputs. The predictions and opinions presented reflect a probabilistic approach, not absolute certainty. All information and data utilized in this article are derived exclusively from publicly available sources; the author possesses no material non-public information and maintains no private communications with company management, insiders, or affiliates. Efforts have been made to ensure accuracy, but inadvertent errors may occur. Readers are advised to independently verify information and conduct their own research. Investing in stocks involves inherent volatility and risk. Before making any investment decisions, it is crucial for readers to conduct thorough research and assess their financial circumstances. The author is not liable for any financial losses incurred as a result of using or relying on the content of this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

$295 million acquisition of two East End centers recycles capital at an over 100 basis point spread, with embedded growth from below-market rents and remerchandising

 | Source:

Kimco Realty Corporation

JERICHO, N.Y., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Kimco Realty® (NYSE: KIM) today announced the $295 million acquisition of Paddock Shops and Shelbyville Road Plaza, two grocery-anchored, open-air shopping centers in Louisville’s East End, home to the metro’s most affluent and desirable trade area. Anchored by Trader Joe’s and The Fresh Market, the centers total over 741,000 square feet and each draw over 4 million annual visits, according to Placer.ai. Combined with Festival at Jefferson Court, the company’s existing Kroger-anchored center, the acquisitions establish Kimco’s dominant grocery-anchored presence in Louisville.

“Paddock Shops and Shelbyville Road Plaza are exactly the kind of centers we want to own: grocery-anchored, in the strongest trade areas of a supply-constrained market,” said Conor Flynn, Chief Executive Officer of Kimco Realty. “We sold lower-growth assets and reinvested the proceeds into higher-growth opportunities that strengthen our presence in a market we find very attractive. These centers also offer meaningful embedded upside through the recapture of below-market leases and the opportunity to further enhance the tenant mix with dynamic brands and specialty retailers.”

Acquisition Highlights

Higher-yield capital recycling: Acquired at a low 6% blended going-in cap rate, over 100 basis points above the approximately 5% average cap rate on Kimco’s 2026 dispositions.Embedded growth: Below-market rents on a number of leases and a clear remerchandising runway, with net operating income underwritten to grow approximately 4% per year over the next ten years.Supply-constrained market: Louisville shopping center vacancy is 3.9%, versus 6% nationally, the market ranks among the top 10 major U.S. markets for occupancy, and no new shopping center space is under construction, according to Cushman & Wakefield.Self-funded, leverage-neutral: Primarily funded with 1031 exchange proceeds from 2026 dispositions. Paddock Shops is a 351,000-square-foot lifestyle center in northeast Louisville, the market’s premier retail corridor, and is 94% leased. Its shopper base has a median household income of approximately $122,000, nearly double the statewide figure, with roughly 60% holding a bachelor’s degree or higher, according to Placer.ai. The center will become part of Kimco’s Lifestyle Collection, the company’s group of signature open-air and mixed-use centers. Shelbyville Road Plaza is a 390,000-square-foot center in St. Matthews, the established retail hub of the Louisville metro, and is 92% leased. Across the two centers, national tenants include REI, Total Wine & More, Pottery Barn, West Elm, ULTA Beauty, Nordstrom Rack, Burlington, Ross Dress for Less and Old Navy.

“Louisville is a market we’ve targeted, and these centers give us meaningful scale in one of the strongest retail corridors,” said Ross Cooper, President and Chief Investment Officer of Kimco Realty. “We see significant opportunity to leverage our One Kimco platform to expand occupancy, drive rent growth and unlock additional value at both properties. Owning Paddock Shops, Shelbyville Road Plaza and Festival at Jefferson Court makes us the first call for retailers entering or expanding in Louisville.”

With the acquisitions, Kimco now owns three grocery-anchored centers in Louisville totaling 911,000 square feet. To view the acquisition slide deck, click here.

CONTACT:
David F. Bujnicki
Senior Vice President, Investor Relations and Strategy
Kimco Realty Corporation
(833) 800-4343
[email protected]

NEW YORK, Nov. 02, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Everest Group, Ltd. (NYSE: EG) between February 8, 2024 and October 27, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 28, 2026.

SO WHAT: If you purchased Everest Group common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Everest Group class action, go to https://rosenlegal.com/cases/everest-group-ltd/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) Everest remained materially exposed to and concentrated in casualty risks subject to escalating claim costs, including business defendants claimed Everest had reduced or exited; (2) Everest had inadequately priced portions of that business; (3) Everest’s reserves were insufficient, causing it to understate its liabilities and expenses and materially overstate its earnings; and (4) addressing these problems would require substantial reserve charges, protection against further adverse development, and reductions in Everest’s casualty business, thereby sacrificing recurring premium revenue. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Everest Group class action, go to https://rosenlegal.com/cases/everest-group-ltd/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      www.rosenlegal.com

Chemours (CC - Free Report) reported $1.54 billion in revenue for the quarter ended September 2026, representing a year-over-year increase of 3%. EPS of $0.21 for the same period compares to $0.20 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.54 billion, representing a surprise of -0.11%. The company delivered an EPS surprise of -19.23%, with the consensus EPS estimate being $0.26.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Chemours performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Net Sales- Thermal & Specialized Solutions: $510 million compared to the $492.44 million average estimate based on four analysts. The reported number represents a change of -8.9% year over year.Net Sales- Titanium Technologies: $680 million compared to the $696.28 million average estimate based on four analysts. The reported number represents a change of +11.1% year over year.Net Sales- Other Non-Reportable Segment: $13 million compared to the $11.26 million average estimate based on four analysts.Net Sales- Advanced Performance Materials: $337 million versus the four-analyst average estimate of $341.65 million. The reported number represents a year-over-year change of +8.4%.Adjusted EBITDA- Titanium Technologies: $85 million compared to the $72.3 million average estimate based on four analysts.Adjusted EBITDA- Corporate and Other: $-46 million compared to the $-39.21 million average estimate based on four analysts.Adjusted EBITDA- Thermal & Specialized Solutions: $136 million compared to the $134.36 million average estimate based on four analysts.Adjusted EBITDA- Advanced Performance Materials: $24 million versus $24.69 million estimated by four analysts on average.Adjusted EBITDA- Other Non-Reportable Segment: $1 million versus $1.61 million estimated by three analysts on average.View all Key Company Metrics for Chemours here>>>

Shares of Chemours have returned -1.3% over the past month versus the Zacks S&P 500 composite's -0.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Okta (OKTA - Free Report) closed the most recent trading day at $184.87, moving -11.22% from the previous trading session. This change lagged the S&P 500's daily loss of 0.51%. Elsewhere, the Dow saw an upswing of 0.41%, while the tech-heavy Nasdaq depreciated by 1.07%.

The cloud identity management company's stock has dropped by 1.54% in the past month, exceeding the Computer and Technology sector's loss of 9.88% and lagging the S&P 500's loss of 0.87%.

The investment community will be closely monitoring the performance of Okta in its forthcoming earnings report. It is anticipated that the company will report an EPS of $0.93, marking a 13.41% rise compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $815.52 million, reflecting a 9.91% rise from the equivalent quarter last year.

Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $3.93 per share and revenue of $3.22 billion. These totals would mark changes of +12.29% and +10.44%, respectively, from last year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Okta. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.

The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Currently, Okta is carrying a Zacks Rank of #3 (Hold).

In the context of valuation, Okta is at present trading with a Forward P/E ratio of 53.03. For comparison, its industry has an average Forward P/E of 53.03, which means Okta is trading at no noticeable deviation to the group.

Also, we should mention that OKTA has a PEG ratio of 3.17. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Security industry currently had an average PEG ratio of 3.23 as of yesterday's close.

The Security industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 67, which puts it in the top 28% of all 250+ industries.

The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.

Shares of both companies fell Monday after Marvell said it reached an all-stock agreement to buy Lumentum.

Corebridge Financial (CRBG - Free Report) came out with quarterly earnings of $1.22 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.96 per share a year ago. These figures are adjusted for non-recurring items.

A quarter ago, it was expected that this financial services company would post earnings of $1.08 per share when it actually produced earnings of $1.12, delivering a surprise of +3.7%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

Corebridge, which belongs to the Zacks Insurance - Multi line industry, posted revenues of $4.5 billion for the quarter ended September 2026, missing the Zacks Consensus Estimate by 5.83%. This compares to year-ago revenues of $5.63 billion. The company has topped consensus revenue estimates just once over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Corebridge shares have added about 15.4% since the beginning of the year versus the S&P 500's gain of 10.7%.

What's Next for Corebridge?While Corebridge has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Corebridge was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.15 on $4.79 billion in revenues for the coming quarter and $4.59 on $17.95 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Insurance - Multi line is currently in the bottom 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Prudential (PRU - Free Report) , has yet to report results for the quarter ended September 2026. The results are expected to be released on November 3.

This financial services company is expected to post quarterly earnings of $3.31 per share in its upcoming report, which represents a year-over-year change of -22.3%. The consensus EPS estimate for the quarter has been revised 9.6% lower over the last 30 days to the current level.

Prudential's revenues are expected to be $13.96 billion, down 14% from the year-ago quarter.

Diamondback Energy (FANG - Free Report) came out with quarterly earnings of $5.86 per share, beating the Zacks Consensus Estimate of $4.92 per share. This compares to earnings of $3.08 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +19.11%. A quarter ago, it was expected that this energy exploration and production company would post earnings of $5.96 per share when it actually produced earnings of $6.48, delivering a surprise of +8.72%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Diamondback, which belongs to the Zacks Oil and Gas - Exploration and Production - United States industry, posted revenues of $5.43 billion for the quarter ended September 2026, surpassing the Zacks Consensus Estimate by 26.46%. This compares to year-ago revenues of $3.92 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Diamondback shares have added about 41.1% since the beginning of the year versus the S&P 500's gain of 10.7%.

What's Next for Diamondback?While Diamondback has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Diamondback was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $5.89 on $4.59 billion in revenues for the coming quarter and $21.49 on $18.99 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Oil and Gas - Exploration and Production - United States is currently in the top 11% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Riley Exploration Permian, Inc. (REPX - Free Report) , has yet to report results for the quarter ended September 2026. The results are expected to be released on November 4.

This company is expected to post quarterly earnings of $2.23 per share in its upcoming report, which represents a year-over-year change of +189.6%. The consensus EPS estimate for the quarter has been revised 26.3% higher over the last 30 days to the current level.

Riley Exploration Permian, Inc.'s revenues are expected to be $159.87 million, up 49.6% from the year-ago quarter.

CRISPR Therapeutics AG (CRSP - Free Report) came out with a quarterly loss of $1.15 per share versus the Zacks Consensus Estimate of a loss of $1.06. This compares to a loss of $1.17 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -8.49%. A quarter ago, it was expected that this company would post a loss of $1.1 per share when it actually produced a loss of $0.94, delivering a surprise of +14.55%.

Over the last four quarters, the company has surpassed consensus EPS estimates just once.

CRISPR Therapeutics, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $12.67 million for the quarter ended September 2026, surpassing the Zacks Consensus Estimate by 27.39%. This compares to year-ago revenues of $0.89 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

CRISPR Therapeutics shares have lost about 2% since the beginning of the year versus the S&P 500's gain of 10.7%.

What's Next for CRISPR Therapeutics?While CRISPR Therapeutics has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for CRISPR Therapeutics was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$1.21 on $10.09 million in revenues for the coming quarter and -$4.44 on $32.45 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 42% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Techne (TECH - Free Report) , is yet to report results for the quarter ended September 2026.

This maker of medical testing and diagnostic products is expected to post quarterly earnings of $0.46 per share in its upcoming report, which represents a year-over-year change of +9.5%. The consensus EPS estimate for the quarter has been revised 1.2% higher over the last 30 days to the current level.

Techne's revenues are expected to be $293.46 million, up 2.4% from the year-ago quarter.

Gold and silver bounced on Monday following Friday's shellacking, helped by a steep decline in crude oil futures that sent US Treasury yields lower across the curve. The continued rally in Treasuries now has benchmark futures on the cusp of a bullish breakout, an outcome that would normally go hand in hand with renewed weakness in the US dollar.